• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

European Pharmaceutical Review Extra

The latest blogs, views and comments on the Pharma world from the leading experts in the industry…



More pharma M&A to come?

Posted on: 25 November 2015 | Author: Garry White, Chief Investment Commentator, Charles Stanley

Viagra maker Pfizer announced on Monday that it would purchase Allergan, the Irish maker of Botox, for about $160bn – the biggest deal ever in the healthcare sector. Could more mega-mergers be in prospect?


Immigration strategies for effectively relocating to the US

Posted on: 6 November 2015 | Author: Ashley Puscas, Associate Attorney at Laura Devine Attorneys

In our globalised economy, it is more common than ever to see pharma companies expanding to establish a presence in multiple markets. Here Ashley Puscas discusses the immigration pathways for pharma seeking to relocate or expand in the US...


Cyber security in pharmaceuticals

Posted on: 22 October 2015 | Author: Caroline Rivett and Dr Cornelius Namiluko at KPMG

Dr Cornelius Namiluko and Caroline Rivett discuss cyber security in the pharmaceutical industry and the approaches companies can take to address the risk of a cyber attack...


2015 Excellence in ADHD Patient Group Awards: Patient advocacy at Shire

Posted on: 20 October 2015 | Author: Victoria White

In the run up to ADHD Awareness Week, European Pharmaceutical Review spoke with Tom Croce, Head of Global Patient Advocacy at Shire, to find out more about the awards and what makes Shire a 'patient-centric' company...

Laboratory Weighing

Improving revenue: Finding the right talent (part 2)

Posted on: 18 November 2013 | Author: Dr Kevin Robinson

The response to a lack of skilled managers is often to take a ‘sticking plaster’ approach to the problem by deciding to take on one or two pricing managers and have them report into the commercial or finance team. Experience to date shows that this will have limited success, for a number of reasons...

Woman Screening Assay Scientist

Improving revenue: Finding the right talent (part 1)

Posted on: 5 November 2013 | Author: Dr Kevin Robinson

Few markets have undergone the degree of change experienced by the life sciences sector in recent years. The end of the blockbuster drug era, the increasing cost of product development and a growing population putting greater strain on healthcare services around the world have combined at a time when economic constraints are putting fierce pressures on the public purse to do more with less...


Omega-3 to the rescue

Posted on: 28 October 2013 | Author: Dr Kevin Robinson

End-users, be they patients or consumers, are taking a good look at the cardiovascular benefits of omega-3s … and tend to like what they see.

Lightbulbs Ideas

Innovation showcase at CPhI Awards 2013

Posted on: 25 October 2013 | Author: Dr Kevin Robinson

It doesn’t seem to matter what the industry is or, indeed, what the event is these days, the same question pops up at regular intervals: where’s the innovation? I’m happy to report that innovation is very much alive and well in the pharmaceutical industry and was on show to the world in Frankfurt at CPhI Worldwide...

Focus on India Map

India announces expanded pharma growth at CPhI

Posted on: 25 October 2013 | Author: Dr Kevin Robinson

CPhI Worldwide 2013: eight halls, more than 30,000 attendees from 140 countries and 2200 exhibitors. The “world's leading pharmaceutical networking event,” colocated with ICSE, P-MEC and InnoPack, was back in Frankfurt, Germany, and my mission was to find a single coherent take-home message...


Webinar: Fit-for-Purpose Miniature NIR Spectroscopy for Solid Dosage ManufacturingREGISTER TO WATCH
+ +